File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1590/S0004-27302009000200012
- Scopus: eid_2-s2.0-67649411827
- PMID: 19466213
- WOS: WOS:000265288400012
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Protective roles of adiponectin in obesityrelated fatty liver diseases: Mechanisms and therapeutic implications | Adiponectina e seu papel na proteção contra a doença hepática gordurosa na obesidade: Mecanismos e implicações terapêuticas
Title | Protective roles of adiponectin in obesityrelated fatty liver diseases: Mechanisms and therapeutic implications | Adiponectina e seu papel na proteção contra a doença hepática gordurosa na obesidade: Mecanismos e implicações terapêuticas |
---|---|
Authors | |
Keywords | Adiponectin Hepatic steatosis Insulin resistance NASH |
Issue Date | 2009 |
Citation | Arquivos Brasileiros De Endocrinologia E Metabologia, 2009, v. 53 n. 2, p. 201-212 How to Cite? |
Abstract | Adiponectin is an insulin-sensitizing adipokine possessing multiple beneficial effects on obesity-related medical complications. This adipokine is secreted from adipocytes into the circulation as three oligomeric isoforms, including trimer, hexamer and the high molecular weight (HMW) oligomeric complex. Each oligomeric isoform of adiponectin possesses distinct biological properties and activates different signaling pathways in various target tissues. The hepato-protective activities have been demonstrated by many clinical and experimental studies. The decreased level of serum adiponectin represents an independent risk factor for nonalcoholic fatty liver disease (NAFLD) and liver dysfunctions in humans. In animals, elevation of circulating adiponectin by either pharmacological or genetic approaches leads to a significant alleviation of hepatomegaly, steatosis and necro-inflammation associated with various liver diseases. In adiponectin knockout mice, there is a pre-existing condition of hepatic steatosis and mitochondria dysfunction, which might contribute to the increased vulnerabilities of these mice to the secondary liver injuries induced by obesity and other conditions. This review aims to summarize recent advances on delination of the structural, molecular and cellular mechanisms underlying the hepato-protective properties of adiponectin. |
Persistent Identifier | http://hdl.handle.net/10722/163256 |
ISSN | 2016 Impact Factor: 1.193 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wang, Y | en_HK |
dc.contributor.author | Mingyan, Z | en_HK |
dc.contributor.author | Lam, KSL | en_HK |
dc.contributor.author | Xu, A | en_HK |
dc.date.accessioned | 2012-09-05T05:29:13Z | - |
dc.date.available | 2012-09-05T05:29:13Z | - |
dc.date.issued | 2009 | en_HK |
dc.identifier.citation | Arquivos Brasileiros De Endocrinologia E Metabologia, 2009, v. 53 n. 2, p. 201-212 | en_HK |
dc.identifier.issn | 0004-2730 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/163256 | - |
dc.description.abstract | Adiponectin is an insulin-sensitizing adipokine possessing multiple beneficial effects on obesity-related medical complications. This adipokine is secreted from adipocytes into the circulation as three oligomeric isoforms, including trimer, hexamer and the high molecular weight (HMW) oligomeric complex. Each oligomeric isoform of adiponectin possesses distinct biological properties and activates different signaling pathways in various target tissues. The hepato-protective activities have been demonstrated by many clinical and experimental studies. The decreased level of serum adiponectin represents an independent risk factor for nonalcoholic fatty liver disease (NAFLD) and liver dysfunctions in humans. In animals, elevation of circulating adiponectin by either pharmacological or genetic approaches leads to a significant alleviation of hepatomegaly, steatosis and necro-inflammation associated with various liver diseases. In adiponectin knockout mice, there is a pre-existing condition of hepatic steatosis and mitochondria dysfunction, which might contribute to the increased vulnerabilities of these mice to the secondary liver injuries induced by obesity and other conditions. This review aims to summarize recent advances on delination of the structural, molecular and cellular mechanisms underlying the hepato-protective properties of adiponectin. | en_HK |
dc.language | eng | en_US |
dc.relation.ispartof | Arquivos Brasileiros de Endocrinologia e Metabologia | en_HK |
dc.subject | Adiponectin | en_HK |
dc.subject | Hepatic steatosis | en_HK |
dc.subject | Insulin resistance | en_HK |
dc.subject | NASH | en_HK |
dc.subject.mesh | Adiponectin - Physiology | en_US |
dc.subject.mesh | Adipose Tissue - Metabolism | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Cardiovascular Diseases - Etiology | en_US |
dc.subject.mesh | Fatty Liver - Etiology - Physiopathology - Therapy | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Insulin Resistance - Physiology | en_US |
dc.subject.mesh | Mice | en_US |
dc.subject.mesh | Mice, Knockout | en_US |
dc.subject.mesh | Obesity - Complications - Metabolism | en_US |
dc.title | Protective roles of adiponectin in obesityrelated fatty liver diseases: Mechanisms and therapeutic implications | Adiponectina e seu papel na proteção contra a doença hepática gordurosa na obesidade: Mecanismos e implicações terapêuticas | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Wang, Y: yuwanghk@hku.hk | en_HK |
dc.identifier.email | Lam, KSL: ksllam@hku.hk | en_HK |
dc.identifier.email | Xu, A: amxu@hkucc.hku.hk | en_HK |
dc.identifier.authority | Wang, Y=rp00239 | en_HK |
dc.identifier.authority | Lam, KSL=rp00343 | en_HK |
dc.identifier.authority | Xu, A=rp00485 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1590/S0004-27302009000200012 | - |
dc.identifier.pmid | 19466213 | en_HK |
dc.identifier.scopus | eid_2-s2.0-67649411827 | en_HK |
dc.identifier.hkuros | 156259 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-67649411827&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 53 | en_HK |
dc.identifier.issue | 2 | en_HK |
dc.identifier.spage | 201 | en_HK |
dc.identifier.epage | 212 | en_HK |
dc.identifier.isi | WOS:000265288400012 | - |
dc.identifier.scopusauthorid | Wang, Y=34973733700 | en_HK |
dc.identifier.scopusauthorid | Mingyan, Z=36712192500 | en_HK |
dc.identifier.scopusauthorid | Lam, KSL=8082870600 | en_HK |
dc.identifier.scopusauthorid | Xu, A=7202655409 | en_HK |
dc.identifier.issnl | 0004-2730 | - |